RIGI and Schwartz-Jampel syndrome: We also reported that hsa‐miR‐628‐3p was significantly upregulated in plasma from patients in the chronic stage of SJS/TEN with SOC and that miR‐628‐3p could regulate innate immunity by suppressing pathogen‐associated molecular patterns such as toll‐like receptor 3 (TLR3), RIG‐I, and MDA‐5.2